Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 4Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Polycystic Ovary Syndrome 1Ovarian Germ Cell Cancer 1Neuroblastoma 1Locally Advanced Cervical Adenocarcinoma 1Infertility 1Ganglioneuroblastoma 1Endodermal Sinus Tumor 1Carcinosarcoma 1

Interventions

Vincristine 2Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Busulfan 2treosulfan 1ganitumab 1etoposide phosphate 1Zoledronic Acid 1Triptorelin Pamoate 1Temozolomide 1Radiosurgery 1Radiation 1Melphalan 1Irinotecan 1FANG vaccine 1Diphosphonates 1Dactinomycin 1Cyproheptadine 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma, Ewing × Congresses as Topic × Clear all
NCT02306161 2026-05-27

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡